Center for Substance Abuse Treatment; Notice of Meeting
| Citation | 86 FR 32952 |
| Record Number | 2021-13132 |
| Published date | 23 June 2021 |
| Section | Notices |
| Court | Substance Abuse And Mental Health Services Administration |
32952
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: SBIR/STTR Commercialization
Readiness Pilot (CRP) Program.
Date: July 15, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Coinfections and HIV Associated
Cancers Study Section.
Date: July 15, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jingsheng Tuo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3196,
Bethesda, MD 20892, 301–451–5953, tuoj@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Infectious Diseases and Immunology Panel C.
Date: July 15–16, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shahrooz Vahedi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 810G,
Bethesda, MD 20892, (301) 496–9322,
vahedis@mail.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
HIV Immunopathogenesis and Vaccine
Development Study Section.
Date: July 15–16, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Reproductive Biology.
Date: July 16, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Yunshang Piao, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
Bethesda, MD 20892, (301) 402–8402,
piaoy3@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Infectious
Diseases and Immunology Research
Enhancement Review.
Date: July 19, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Human Complex Mental Function.
Date: July 19, 2021.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Pamela Jeter, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 10J08,
Bethesda, MD 20892, (301) 435–2591,
pamela.jeter@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in infectious diseases
vaccines, therapeutics and vector biology.
Date: July 20, 2021.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 3200,
MSC 7808, Bethesda, MD 20892, 301–435–
1167, pandyaga@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 17, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–13184 Filed 6–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Center for Substance Abuse
Treatment; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council
(NAC) will meet on August 12, 2021,
1:00 p.m.–4:30 p.m. (EDT).
The meeting is open to the public and
will include consideration of minutes
from the SAMHSA CSAT NAC meeting
of March 31, 2021; an update on CSAT
activities; a discussion with SAMHSA
leadership; and discussion of recovery
and recovery support. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the Council. Written
submissions should be forwarded to the
contact person on or before August 6,
2021. Oral presentations from the public
will be scheduled at the conclusion of
the meeting. Individuals interested in
making oral presentations must notify
the contact person on or before August
6, 2021. Five minutes will be allotted for
each presentation.
The meeting will be conducted via
WebEx and telephone only, and
registration is required to participate
during this me. To attend virtually, or
to obtain the call-in number and access
code, submit written or brief oral
comments, or request special
accommodations for persons with
disabilities, please register on-line at
http://snacregister.samhsa.gov/
MeetingList.aspx, or communicate with
the CSAT National Advisory Council
Designated Federal Officer; Tracy Goss
(see contact information below).
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee
website at http://www.samhsa.gov/
about-us/advisory-councils/csat-
national-advisory-council or by
contacting the CSAT National Advisory
Council Designated Federal Officer.
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: August 12, 2021,
1:00 p.m.–4:30 p.m. EDT, OPEN.
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
VerDate Sep<11>2014 17:13 Jun 22, 2021 Jkt 253001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1
jbell on DSKJLSW7X2PROD with NOTICES
32953
Federal Register / Vol. 86, No. 118 / Wednesday, June 23, 2021 / Notices
1
The Protecting and Securing Chemical Facilities
from Terrorist Attacks Act of 2014 (also known as
the CFATS Act of 2014, Pub. L. 113–254) codified
the CFATS program into the Homeland Security
Act of 2002. See 6 U.S.C. 621 et seq., as amended
by Public Law 116–136, Sec. 16007 (2020).
2
The recordkeeping burden for facilities under
CFATS is accounted for by CISA under the CSAT
Information Collection No. 1670–0007.
Telephone: (240) 276–0759, Email:
tracy.goss@samhsa.hhs.gov.
Dated: June 16, 2021.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2021–13132 Filed 6–22–21; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. CISA–2021–0003]
Notice of Request for Revision of a
Currently Approved Information
Collection for the Chemical Facility
Anti-Terrorism Standards (CFATS)
AGENCY
: Cybersecurity and
Infrastructure Security Agency, DHS.
ACTION
: 30-Day notice and request for
comments; revision of Information
Collection Request: 1670–0014.
Authority: 6 U.S.C. 621–629.
SUMMARY
: The Infrastructure Security
Division (ISD) within the Cybersecurity
and Infrastructure Security Agency
(CISA) is issuing a 60-day notice and
request for comments to revise
Information Collection Request (ICR)
1670–0014. CISA will submit the ICR to
the Office of Management and Budget
(OMB) for review and clearance in
accordance with the Paperwork
Reduction Act of 1995. DHS previously
published this information collection
request (ICR), in the Federal Register,
on Monday, March 23, 2021 at 86 FR
15490 for a 60-day public comment
period. No comments was/were
received by DHS. To access and review
all documents related to this
information collection, please visit the
Federal eRulemaking Portal site at
http://www.regulations.gov and enter
Docket Number CISA–2021–0003 in the
search box. The purpose of this notice
is to allow an additional 30 days for
public comments.
DATES
: Comments are encouraged and
will be accepted until August 23, 2021.
ADDRESSES
: You may submit comments,
identified by docket number CISA–
2021–0003 through the Federal
eRulemaking Portal available at http://
www.regulations.gov. Follow the
instructions for submitting comments.
Instructions: All comments received
via https://www.regulations.gov will be
posted to the public docket at https://
www.regulations.gov, including any
personal information provided.
Do not submit comments that include
trade secrets, confidential commercial
or financial information, Chemical-
terrorism Vulnerability Information
(CVI), Protected Critical Infrastructure
Information (PCII), or Sensitive Security
Information (SSI) directly to the public
regulatory docket. Contact the
individual listed in the
FOR FURTHER
INFORMATION CONTACT
section below
with questions about comments
containing protected information. CISA
will not place comments containing
protected information in the public
docket and will handle them in
accordance with applicable safeguards
and restrictions on access. Comments
containing protected information will be
held in a separate file to which the
public does not have access and CISA
will place a note in the public docket
documenting receipt of the comment. If
CISA receives a request to examine or
copy this information, CISA will treat it
as any other request under the Freedom
of Information Act (FOIA), 5 U.S.C. 552,
and the Department’s FOIA regulation
found in part 5 of Title 6 of the Code
of Federal Regulations (CFR).
FOR FURTHER INFORMATION CONTACT
:
Lona Saccomando, 703–235–5263,
CISARegulations@cisa.dhs.gov.
SUPPLEMENTARY INFORMATION
: The
CFATS Program identifies chemical
facilities of interest and regulates the
security of high-risk chemical facilities
through a risk-based approach. The
CFATS Program is authorized under the
Protecting and Securing Chemical
Facilities from Terrorist Attacks Act of
2014
1
or ‘‘CFATS Act of 2014’’. CISA
collects necessary information through
1670–0014 to implement CFATS.
CISA’s Methodology in Estimating the
Burden for the Request for
Redetermination
This instrument collects information
to support a facility’s request for
redetermination of high-risk which
CISA is obligated to perform pursuant to
the CFATS Act of 2014. The collection
of information may be concurrent with
a facility’s submission of a Top-Screen
pursuant to 6 CFR 27.210(d) or collected
after CISA reviews a Top-Screen that
reflects material modifications made by
the facility. This instrument authorizes
CISA to collect both the reason for the
redetermination as well as supporting
documentation.
CISA is proposing minor revisions to
the instrument that reflect the passage of
the Cybersecurity and Infrastructure
Security Act of 2018, 6 U.S.C. 651–74,
such as updating the Agency name to
conform with the Agency’s new
designation as CISA, as well as a clearer
description of the scope of the
instrument. The scope of this
instrument remains unchanged.
Number of Respondents
The current information collection
estimated that 625 respondents would
submit a request for a Request for
Redetermination annually. Based on
data collected between CY 2018–2020,
215 respondents, on average, submitted
a Request for Redetermination annually.
Because of the historical pattern of
lower submissions over the past three
years, CISA proposes to decrease the
estimated number of respondents from
625 to 250 respondents. CISA will retain
the number of responses per respondent
of 1.0.
Estimated Time per Respondent
In the current information collection,
the estimated time per respondent to
prepare and submit a Request for
Redetermination is 0.25 hours (15
minutes). CISA continues to believe this
is a reasonable burden estimate for this
instrument.
Annual Burden Hours
The annual burden hours for a
Request for Redetermination is [0.25
hours × 250 respondents × 1 response
per respondent], which equals 62.5
hours.
Total Capital/Startup Burden Cost
CISA provides access to CSAT free of
charge and assumes that each
respondent already has computer
hardware and access to the internet for
basic business needs. Therefore, there
are no annualized capital or start-up
costs incurred by chemical facilities of
interest or high-risk chemical facilities
for this information collection.
Total Recordkeeping Burden
There are no recordkeeping burden
costs incurred by chemical facilities of
interest or high-risk chemical facilities
for this information collection.
2
Total Annual Burden Cost
CISA assumes that Site Security
Officers (SSOs) are responsible for
submitting a Request for
Redetermination. For the purpose of this
notice, CISA maintains this assumption.
Therefore, to estimate the total annual
burden, CISA multiplied the annual
burden of 62.5 hours by the average
hourly wage rate of SSOs which is
VerDate Sep<11>2014 17:13 Jun 22, 2021 Jkt 253001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\23JNN1.SGM 23JNN1
jbell on DSKJLSW7X2PROD with NOTICES
